Citations 1225

P1‐083: Association between direct medical costs and reduced cognitive function within categories of normal cognition and mild cognitive impairment

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_4 | Pages: No page available

10.1016/j.jalz.2012.05.359

O1‐10‐01: Clinical outcomes for stages of NIA‐AA preclinical Alzheimer's disease

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2012.05.257

P2‐075: Biomarker correlates in the ADNI Alzheimer's disease dementia population suggesting dementia unlikely due to Alzheimer's

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_8 | Pages: No page available

10.1016/j.jalz.2012.05.779

O4‐01‐01: Classification of MCI and Alzheimer's disease from CSF biomarkers: An ADNI study of Aß, tau and P‐tau versus 83 proteomic analytes

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2012.05.1634

P3‐271: Automated index of semantic verbal fluency in mild cognitive impairment and Alzheimer's disease

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2012.05.1494

IC‐P‐014: Infarctions on antemortem MRI are associated with the presence of microinfarcts at autopsy

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2012.05.046

IC‐P‐109: Nonstationarity in the modular architecture of the “resting brain”

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2012.05.143

P1‐173: A kindred with familial frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2012.05.451

P1‐201: Identification of human disease‐associated variants in a brain expression genome‐wide association study (eGWAS)

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2012.05.480

The epidemiology of Alzheimer's disease: Laying the foundation for drug design, conduct, and analysis of clinical trials

Alzheimer's & Dementia | July 3, 2012 | Volume: 8 | Issue: 3 | Pages: 237-242

10.1016/j.jalz.2011.12.005 | PMID 22546356

AbstractEpidemiological studies increasingly inform Alzheimer's disease (AD) public health impact, prevention strategies, drug targets, therapeutic interventions, and clinical trial design. For this reason, the Alzheimer's Association Research Roundtable convened an international group of AD experts with experience in conducting both observational and clinical trials for a meeting on October 19 and 20, 2010, in Washington, DC, to discuss the role of epidemiologic studies in AD research and therapeutic advances. Topics included wellness markers and risk factors, with a focus on special populations such as those at elevated risk, super agers, and underserved populations. Discussions also highlighted lessons learned from observational studies of aging, cardiovascular disease, and other disease areas, as well as how new technologies have enabled the gathering of data relevant to drug development and clinical trial conduct.